Literature DB >> 26158395

Predictive and comparative analysis of Ebolavirus proteins.

Qian Cong1, Jimin Pei, Nick V Grishin.   

Abstract

Ebolavirus is the pathogen for Ebola Hemorrhagic Fever (EHF). This disease exhibits a high fatality rate and has recently reached a historically epidemic proportion in West Africa. Out of the 5 known Ebolavirus species, only Reston ebolavirus has lost human pathogenicity, while retaining the ability to cause EHF in long-tailed macaque. Significant efforts have been spent to determine the three-dimensional (3D) structures of Ebolavirus proteins, to study their interaction with host proteins, and to identify the functional motifs in these viral proteins. Here, in light of these experimental results, we apply computational analysis to predict the 3D structures and functional sites for Ebolavirus protein domains with unknown structure, including a zinc-finger domain of VP30, the RNA-dependent RNA polymerase catalytic domain and a methyltransferase domain of protein L. In addition, we compare sequences of proteins that interact with Ebolavirus proteins from RESTV-resistant primates with those from RESTV-susceptible monkeys. The host proteins that interact with GP and VP35 show an elevated level of sequence divergence between the RESTV-resistant and RESTV-susceptible species, suggesting that they may be responsible for host specificity. Meanwhile, we detect variable positions in protein sequences that are likely associated with the loss of human pathogenicity in RESTV, map them onto the 3D structures and compare their positions to known functional sites. VP35 and VP30 are significantly enriched in these potential pathogenicity determinants and the clustering of such positions on the surfaces of VP35 and GP suggests possible uncharacterized interaction sites with host proteins that contribute to the virulence of Ebolavirus.

Entities:  

Keywords:  Ebolavirus; Pathogenicity; comparative analysis; functional site prediction; structure prediction

Mesh:

Substances:

Year:  2015        PMID: 26158395      PMCID: PMC4615121          DOI: 10.1080/15384101.2015.1068472

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  123 in total

1.  RNA synthesis in a cage--structural studies of reovirus polymerase lambda3.

Authors:  Yizhi Tao; Diane L Farsetta; Max L Nibert; Stephen C Harrison
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

2.  Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.

Authors:  Ziying Han; Hani Boshra; J Oriol Sunyer; Susan H Zwiers; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  Covalent modifications of the ebola virus glycoprotein.

Authors:  Scott A Jeffers; David Avram Sanders; Anthony Sanchez
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Ebola virus transcription activator VP30 is a zinc-binding protein.

Authors:  Jens Modrof; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding.

Authors:  Rekha G Panchal; Gordon Ruthel; Tara A Kenny; George H Kallstrom; Douglas Lane; Shirin S Badie; Limin Li; Sina Bavari; M Javad Aman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

7.  Protein disorder prediction: implications for structural proteomics.

Authors:  Rune Linding; Lars Juhl Jensen; Francesca Diella; Peer Bork; Toby J Gibson; Robert B Russell
Journal:  Structure       Date:  2003-11       Impact factor: 5.006

8.  The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein.

Authors:  Yue Huang; Ling Xu; Yongnian Sun; Gary J Nabel
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

9.  Crystal structure of the borna disease virus nucleoprotein.

Authors:  Markus G Rudolph; Ina Kraus; Achim Dickmanns; Markus Eickmann; Wolfgang Garten; Ralf Ficner
Journal:  Structure       Date:  2003-10       Impact factor: 5.006

10.  DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

Authors:  Graham Simmons; Jacqueline D Reeves; Case C Grogan; Luk H Vandenberghe; Frédéric Baribaud; J Charles Whitbeck; Emily Burke; Michael J Buchmeier; Elizabeth J Soilleux; James L Riley; Robert W Doms; Paul Bates; Stefan Pöhlmann
Journal:  Virology       Date:  2003-01-05       Impact factor: 3.616

View more
  5 in total

1.  Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription.

Authors:  Andrey Ivanov; Palaniappan Ramanathan; Christian Parry; Philipp A Ilinykh; Xionghao Lin; Michael Petukhov; Yuri Obukhov; Tatiana Ammosova; Gaya K Amarasinghe; Alexander Bukreyev; Sergei Nekhai
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

2.  Mapping the clinical outcomes and genetic evolution of Ebola virus in Sierra Leone.

Authors:  Tao Li; Hong-Wu Yao; Di Liu; Hong-Guang Ren; Yi Hu; David Kargbo; Yue Teng; Yong-Qiang Deng; Hui-Jun Lu; Xiong Liu; Kun Liu; Li-Qun Fang; Nian-Zhi Ning; Gary Wong; Foday Dafae; Abdul Kamara; AiPing Wu; Tai-Jiao Jiang; Zhan Li; Jie Huang; Yu Sun; Jun Qian; Brima Kargbo; Jia-Fu Jiang; Hui Wang; Wu-Chun Cao
Journal:  JCI Insight       Date:  2017-08-03

3.  The first complete genomes of Metalmarks and the classification of butterfly families.

Authors:  Qian Cong; Jinhui Shen; Wenlin Li; Dominika Borek; Zbyszek Otwinowski; Nick V Grishin
Journal:  Genomics       Date:  2017-07-28       Impact factor: 5.736

4.  Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.

Authors:  Satoko Yamaoka; Hideki Ebihara
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Characterization of the catalytic center of the Ebola virus L polymerase.

Authors:  Marie Luisa Schmidt; Thomas Hoenen
Journal:  PLoS Negl Trop Dis       Date:  2017-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.